Serum Inflamma-miR Signature: A Biomarker of Myelodysplastic Syndrome?
Front Oncol
.
2020 Nov 20:10:595838.
doi: 10.3389/fonc.2020.595838.
eCollection 2020.
Authors
Marianna Mariani
1
,
Domenico Mattiucci
1
,
Elisa Rossi
1
,
Valeria Mari
1
,
Erico Masala
2
,
Angelica Giuliani
3
,
Valeria Santini
2
,
Fabiola Olivieri
3
4
,
Elena Marinelli Busilacchi
1
,
Stefania Mancini
1
,
Attilio Olivieri
1
,
Antonella Poloni
1
Affiliations
1
Hematology Clinic, Department of Clinical and Molecular Sciences, DISCLIMO, AOU Ospedali Riuniti-Università Politecnica delle Marche, Ancona, Italy.
2
MDS Unit, Azienda Ospedaliero Universitaria Careggi, University of Florence, Florence, Italy.
3
Department of Clinical and Molecular Sciences, DISCLIMO, Università Politecnica delle Marche, Ancona, Italy.
4
Center of Clinical Pathology and Innovative Therapy, IRCCS INRCA National Institute, Ancona, Italy.
PMID:
33330086
PMCID:
PMC7713643
DOI:
10.3389/fonc.2020.595838
No abstract available
Keywords:
biomarkers; inflammaging; inflammation; microRNAs; myelodysplastic syndromes.